{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:35:00Z","timestamp":1791318900327,"version":"4.3.1"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,2,27]],"date-time":"2015-02-27T00:00:00Z","timestamp":1424995200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s40263-015-0236-0","type":"journal-article","created":{"date-parts":[[2015,2,26]],"date-time":"2015-02-26T09:53:09Z","timestamp":1424944389000},"page":"265-275","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":133,"title":["Targeting the Serotonin 5-HT7 Receptor in the Search for Treatments for CNS Disorders: Rationale and Progress to Date"],"prefix":"10.1007","volume":"29","author":[{"given":"Agnieszka","family":"Nikiforuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,27]]},"reference":[{"issue":"31","key":"236_CR1","doi-asserted-by":"crossref","first-page":"23422","DOI":"10.1016\/S0021-9258(19)49479-9","volume":"268","author":"JA Bard","year":"1993","unstructured":"Bard JA, Zgombick J, Adham N, Vaysse P, Branchek TA, Weinshank RL. Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase. J Biol Chem. 1993;268(31):23422\u20136.","journal-title":"J Biol Chem."},{"issue":"3","key":"236_CR2","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0896-6273(93)90149-L","volume":"11","author":"TW Lovenberg","year":"1993","unstructured":"Lovenberg TW, Baron BM, de Lecea L, Miller JD, Prosser RA, Rea MA, Foye PE, Racke M, Slone AL, Siegel BW. A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms. Neuron. 1993;11(3):449\u201358.","journal-title":"Neuron."},{"issue":"18","key":"236_CR3","doi-asserted-by":"crossref","first-page":"8547","DOI":"10.1073\/pnas.90.18.8547","volume":"90","author":"M Ruat","year":"1993","unstructured":"Ruat M, Traiffort E, Leurs R, Tardivel-Lacombe J, Diaz J, Arrang JM, Schwartz JC. Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. Proc Natl Acad Sci. 1993;90(18):8547\u201351.","journal-title":"Proc Natl Acad Sci"},{"issue":"12","key":"236_CR4","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/S0028-3908(98)00070-7","volume":"37","author":"DE Heidmann","year":"1998","unstructured":"Heidmann DE, Szot P, Kohen R, Hamblin MW. Function and distribution of three rat 5-hydroxytryptamine7 (5-HT7) receptor isoforms produced by alternative splicing. Neuropharmacology. 1998;37(12):1621\u201332.","journal-title":"Neuropharmacology."},{"issue":"6","key":"236_CR5","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s002100000369","volume":"363","author":"KA Krobert","year":"2001","unstructured":"Krobert KA, Bach T, Syversveen T, Kvingedal AM, Levy FO. The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution. Naunyn Schmiedebergs Arch Pharmacol. 2001;363(6):620\u201332.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"issue":"3","key":"236_CR6","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1124\/jpet.104.081919","volume":"313","author":"CR Guthrie","year":"2005","unstructured":"Guthrie CR, Murray AT, Franklin AA, Hamblin MW. Differential agonist-mediated internalization of the human 5-hydroxytryptamine 7 receptor isoforms. J Pharmacol Exp Ther. 2005;313(3):1003\u201310.","journal-title":"J Pharmacol Exp Ther."},{"issue":"34","key":"236_CR7","doi-asserted-by":"crossref","first-page":"7821","DOI":"10.1523\/JNEUROSCI.1790-05.2005","volume":"25","author":"E Kvachnina","year":"2005","unstructured":"Kvachnina E, Liu G, Dityatev A, Renner U, Dumuis A, Richter DW, Dityateva G, Schachner M, Voyno-Yasenetskaya TA, Ponimaskin EG. 5-HT7 receptor is coupled to G alpha subunits of heterotrimeric G12-protein to regulate gene transcription and neuronal morphology. J Neurosci. 2005;25(34):7821\u201330.","journal-title":"J Neurosci."},{"issue":"11","key":"236_CR8","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.bbamcr.2009.08.008","volume":"1793","author":"E Kvachnina","year":"2009","unstructured":"Kvachnina E, Dumuis A, Wlodarczyk J, Renner U, Cochet M, Richter DW, Ponimaskin E. Constitutive Gs-mediated, but not G12-mediated, activity of the 5-hydroxytryptamine 5-HT7(a) receptor is modulated by the palmitoylation of its C-terminal domain. Biochim Biophys Acta. 2009;1793(11):1646\u201355.","journal-title":"Biochim Biophys Acta."},{"issue":"9","key":"236_CR9","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1523\/JNEUROSCI.2765-11.2012","volume":"32","author":"F Kobe","year":"2012","unstructured":"Kobe F, Guseva D, Jensen TP, Wirth A, Renner U, Hess D, Muller M, Medrihan L, Zhang W, Zhang M, Braun K, Westerholz S, Herzog A, Radyushkin K, El-Kordi A, Ehrenreich H, Richter DW, Rusakov DA, Ponimaskin E. 5-HT7R\/G12 signaling regulates neuronal morphology and function in an age-dependent manner. J Neurosci. 2012;32(9):2915\u201330.","journal-title":"J Neurosci."},{"issue":"4","key":"236_CR10","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00213-010-2001-x","volume":"212","author":"M Teitler","year":"2010","unstructured":"Teitler M, Toohey N, Knight JA, Klein MT, Smith C. Clozapine and other competitive antagonists reactivate risperidone-inactivated h5-HT7 receptors: radioligand binding and functional evidence for GPCR homodimer protomer interactions. Psychopharmacology (Berl). 2010;212(4):687\u201397.","journal-title":"Psychopharmacology (Berl)."},{"issue":"Pt 10","key":"236_CR11","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1242\/jcs.101337","volume":"125","author":"U Renner","year":"2012","unstructured":"Renner U, Zeug A, Woehler A, Niebert M, Dityatev A, Dityateva G, Gorinski N, Guseva D, Abdel-Galil D, Frohlich M, Doring F, Wischmeyer E, Richter DW, Neher E, Ponimaskin EG. Heterodimerization of serotonin receptors 5-HT1A and 5-HT7 differentially regulates receptor signalling and trafficking. J Cell Sci. 2012;125(Pt 10):2486\u201399.","journal-title":"J Cell Sci."},{"issue":"4","key":"236_CR12","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1021\/jm980519u","volume":"42","author":"C Kikuchi","year":"1999","unstructured":"Kikuchi C, Nagaso H, Hiranuma T, Koyama M. Tetrahydrobenzindoles: selective antagonists of the 5-HT7 receptor. J Med Chem. 1999;42(4):533\u20135.","journal-title":"J Med Chem."},{"issue":"6","key":"236_CR13","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/sj.bjp.0701946","volume":"124","author":"DR Thomas","year":"1998","unstructured":"Thomas DR, Gittins SA, Collin LL, Middlemiss DN, Riley G, Hagan J, Gloger I, Ellis CE, Forbes IT, Brown AM. Functional characterisation of the human cloned 5-HT7 receptor (long form); antagonist profile of SB-258719. Br J Pharmacol. 1998;124(6):1300\u20136.","journal-title":"Br J Pharmacol."},{"issue":"3","key":"236_CR14","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/sj.bjp.0703357","volume":"130","author":"JJ Hagan","year":"2000","unstructured":"Hagan JJ, Price GW, Jeffrey P, Deeks NJ, Stean T, Piper D, Smith MI, Upton N, Medhurst AD, Middlemiss DN, Riley GJ, Lovell PJ, Bromidge SM, Thomas DR. Characterization of SB-269970-A, a selective 5-HT(7) receptor antagonist. Br J Pharmacol. 2000;130(3):539\u201348.","journal-title":"Br J Pharmacol."},{"issue":"4","key":"236_CR15","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/sj.bjp.0705290","volume":"139","author":"DR Thomas","year":"2003","unstructured":"Thomas DR, Melotto S, Massagrande M, Gribble AD, Jeffrey P, Stevens AJ, Deeks NJ, Eddershaw PJ, Fenwick SH, Riley G, Stean T, Scott CM, Hill MJ, Middlemiss DN, Hagan JJ, Price GW, Forbes IT. SB-656104-A, a novel selective 5-HT7 receptor antagonist, modulates REM sleep in rats. Br J Pharmacol. 2003;139(4):705\u201314.","journal-title":"Br J Pharmacol."},{"issue":"2","key":"236_CR16","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1124\/jpet.112.193995","volume":"342","author":"P Bonaventure","year":"2012","unstructured":"Bonaventure P, Dugovic C, Kramer M, De Boer P, Singh J, Wilson S, Bertelsen K, Di J, Shelton J, Aluisio L, Dvorak L, Fraser I, Lord B, Nepomuceno D, Ahnaou A, Drinkenburg W, Chai W, Dvorak C, Sands S, Carruthers N, Lovenberg TW. Translational evaluation of JNJ-18038683, a 5-hydroxytryptamine type 7 receptor antagonist, on rapid eye movement sleep and in major depressive disorder. J Pharmacol Exp Ther. 2012;342(2):429\u201340.","journal-title":"J Pharmacol Exp Ther."},{"issue":"3","key":"236_CR17","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1515\/revneuro-2014-0009","volume":"25","author":"P Pilato Di","year":"2014","unstructured":"Di Pilato P, Niso M, Adriani W, Romano E, Travaglini D, Berardi F, Colabufo NA, Perrone R, Laviola G, Lacivita E, Leopoldo M. Selective agonists for serotonin 7 (5-HT7) receptor and their applications in preclinical models: an overview. Rev Neurosci. 2014;25(3):401\u201315.","journal-title":"Rev Neurosci."},{"issue":"3","key":"236_CR18","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pain.2008.11.009","volume":"141","author":"A Brenchat","year":"2009","unstructured":"Brenchat A, Romero L, Garcia M, Pujol M, Burgueno J, Torrens A, Hamon M, Baeyens JM, Buschmann H, Zamanillo D, Vela JM. 5-HT7 receptor activation inhibits mechanical hypersensitivity secondary to capsaicin sensitization in mice. Pain. 2009;141(3):239\u201347.","journal-title":"Pain."},{"issue":"17","key":"236_CR19","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1021\/jm070487n","volume":"50","author":"M Leopoldo","year":"2007","unstructured":"Leopoldo M, Lacivita E, Contino M, Colabufo NA, Berardi F, Perrone R. Structure-activity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides, a class of 5-HT7 receptor agents. 2. J Med Chem. 2007;50(17):4214\u201321.","journal-title":"J Med Chem."},{"issue":"18","key":"236_CR20","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.1021\/jm800615e","volume":"51","author":"M Leopoldo","year":"2008","unstructured":"Leopoldo M, Lacivita E, De Giorgio P, Fracasso C, Guzzetti S, Caccia S, Contino M, Colabufo NA, Berardi F, Perrone R. Structural modifications of N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides: influence on lipophilicity and 5-HT7 receptor activity. Part III. J Med Chem. 2008;51(18):5813\u201322.","journal-title":"J Med Chem."},{"issue":"4","key":"236_CR21","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.neuropharm.2004.11.015","volume":"48","author":"M Guscott","year":"2005","unstructured":"Guscott M, Bristow LJ, Hadingham K, Rosahl TW, Beer MS, Stanton JA, Bromidge F, Owens AP, Huscroft I, Myers J, Rupniak NM, Patel S, Whiting PJ, Hutson PH, Fone KC, Biello SM, Kulagowski JJ, McAllister G. Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression. Neuropharmacology. 2005;48(4):492\u2013502.","journal-title":"Neuropharmacology."},{"issue":"10","key":"236_CR22","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.biopsych.2005.05.012","volume":"58","author":"PB Hedlund","year":"2005","unstructured":"Hedlund PB, Huitron-Resendiz S, Henriksen SJ, Sutcliffe JG. 5-HT7 receptor inhibition and inactivation induce antidepressant like behavior and sleep pattern. Biol Psychiatry. 2005;58(10):831\u20137.","journal-title":"Biol Psychiatry."},{"issue":"1","key":"236_CR23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bbr.2010.01.022","volume":"209","author":"G Sarkisyan","year":"2010","unstructured":"Sarkisyan G, Roberts AJ, Hedlund PB. The 5-HT(7) receptor as a mediator and modulator of antidepressant-like behavior. Behav Brain Res. 2010;209(1):99\u2013108.","journal-title":"Behav Brain Res."},{"issue":"2","key":"236_CR24","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1124\/jpet.107.119404","volume":"321","author":"P Bonaventure","year":"2007","unstructured":"Bonaventure P, Kelly L, Aluisio L, Shelton J, Lord B, Galici R, Miller K, Atack J, Lovenberg TW, Dugovic C. Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents. J Pharmacol Exp Ther. 2007;321(2):690\u20138.","journal-title":"J Pharmacol Exp Ther."},{"issue":"3","key":"236_CR25","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.neuropharm.2006.04.017","volume":"51","author":"A Wesolowska","year":"2006","unstructured":"Wesolowska A, Nikiforuk A, Stachowicz K, Tatarczynska E. Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression. Neuropharmacology. 2006;51(3):578\u201386.","journal-title":"Neuropharmacology."},{"issue":"4","key":"236_CR26","first-page":"464","volume":"60","author":"A Wesolowska","year":"2008","unstructured":"Wesolowska A, Kowalska M. Influence of serotonin 5-HT(7) receptor blockade on the behavioral and neurochemical effects of imipramine in rats. Pharmacol Rep. 2008;60(4):464\u201374.","journal-title":"Pharmacol Rep."},{"issue":"6","key":"236_CR27","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/npp.2011.13","volume":"36","author":"O Mnie-Filali","year":"2011","unstructured":"Mnie-Filali O, Faure C, Lambas-Senas L, El MM, Belblidia H, Gondard E, Etievant A, Scarna H, Didier A, Berod A, Blier P, Haddjeri N. Pharmacological blockade of 5-HT7 receptors as a putative fast acting antidepressant strategy. Neuropsychopharmacology. 2011;36(6):1275\u201388.","journal-title":"Neuropsychopharmacology."},{"issue":"1","key":"236_CR28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejphar.2006.10.001","volume":"555","author":"A Wesolowska","year":"2007","unstructured":"Wesolowska A, Tatarczynska E, Nikiforuk A, Chojnacka-Wojcik E. Enhancement of the anti-immobility action of antidepressants by a selective 5-HT7 receptor antagonist in the forced swimming test in mice. Eur J Pharmacol. 2007;555(1):43\u20137.","journal-title":"Eur J Pharmacol."},{"issue":"1","key":"236_CR29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00213-009-1521-8","volume":"205","author":"AI Abbas","year":"2009","unstructured":"Abbas AI, Hedlund PB, Huang XP, Tran TB, Meltzer HY, Roth BL. Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo. Psychopharmacology (Berl). 2009;205(1):119\u201328.","journal-title":"Psychopharmacology (Berl)."},{"key":"236_CR30","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.neuropharm.2013.01.023","volume":"70","author":"LN Cates","year":"2013","unstructured":"Cates LN, Roberts AJ, Huitron-Resendiz S, Hedlund PB. Effects of lurasidone in behavioral models of depression. Role of the 5-HT(7) receptor subtype. Neuropharmacology. 2013;70:211\u20137.","journal-title":"Neuropharmacology."},{"issue":"4","key":"236_CR31","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s002130050456","volume":"134","author":"P Willner","year":"1997","unstructured":"Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology (Berl). 1997;134(4):319\u201329.","journal-title":"Psychopharmacology (Berl)."},{"issue":"3","key":"236_CR32","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1515\/revneuro-2014-0017","volume":"25","author":"JA Terron","year":"2014","unstructured":"Terron JA. Novel insights into the potential involvement of 5-HT7 receptors in endocrine dysregulation in stress-related disorders. Rev Neurosci. 2014;25(3):439\u201349.","journal-title":"Rev Neurosci."},{"key":"236_CR33","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.neuropharm.2013.03.013","volume":"71","author":"BB Garcia-Iglesias","year":"2013","unstructured":"Garcia-Iglesias BB, Mendoza-Garrido ME, Gutierrez-Ospina G, Rangel-Barajas C, Noyola-Diaz M, Terron JA. Sensitization of restraint-induced corticosterone secretion after chronic restraint in rats: involvement of 5-HT(7) receptors. Neuropharmacology. 2013;71:216\u201327.","journal-title":"Neuropharmacology."},{"issue":"2","key":"236_CR34","first-page":"83","volume":"60","author":"K Tokarski","year":"2009","unstructured":"Tokarski K, Pitra P, Duszynska B, Hess G. Imipramine counteracts corticosterone-induced alterations in the effects of the activation of 5-HT(7) receptors in rat hippocampus. J Physiol Pharmacol. 2009;60(2):83\u20138.","journal-title":"J Physiol Pharmacol."},{"issue":"6","key":"236_CR35","first-page":"663","volume":"62","author":"K Tokarski","year":"2011","unstructured":"Tokarski K, Bobula B, Kusek M, Hess G. The 5-HT(7) receptor antagonist SB 269970 counteracts restraint stress-induced attenuation of long-term potentiation in rat frontal cortex. J Physiol Pharmacol. 2011;62(6):663\u20137.","journal-title":"J Physiol Pharmacol."},{"issue":"3","key":"236_CR36","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.pnpbp.2009.01.006","volume":"33","author":"YC Li","year":"2009","unstructured":"Li YC, Wang FM, Pan Y, Qiang LQ, Cheng G, Zhang WY, Kong LD. Antidepressant-like effects of curcumin on serotonergic receptor-coupled AC-cAMP pathway in chronic unpredictable mild stress of rats. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(3):435\u201349.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"issue":"1","key":"236_CR37","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bbr.2011.09.006","volume":"226","author":"A Nikiforuk","year":"2012","unstructured":"Nikiforuk A. Selective blockade of 5-HT7 receptors facilitates attentional set-shifting in stressed and control rats. Behav Brain Res. 2012;226(1):118\u201323.","journal-title":"Behav Brain Res."},{"issue":"3","key":"236_CR38","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1515\/revneuro-2014-0016","volume":"25","author":"JM Monti","year":"2014","unstructured":"Monti JM, Jantos H. The role of serotonin 5-HT7 receptor in regulating sleep and wakefulness. Rev Neurosci. 2014;25(3):429\u201337.","journal-title":"Rev Neurosci."},{"issue":"2","key":"236_CR39","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.pbb.2012.05.012","volume":"102","author":"JM Monti","year":"2012","unstructured":"Monti JM, Leopoldo M, Jantos H, Lagos P. Microinjection of the 5-HT7 receptor antagonist SB-269970 into the rat brainstem and basal forebrain: site-dependent effects on REM sleep. Pharmacol Biochem Behav. 2012;102(2):373\u201380.","journal-title":"Pharmacol Biochem Behav."},{"issue":"2","key":"236_CR40","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.neuropharm.2008.09.014","volume":"56","author":"J Shelton","year":"2009","unstructured":"Shelton J, Bonaventure P, Li X, Yun S, Lovenberg T, Dugovic C. 5-HT7 receptor deletion enhances REM sleep suppression induced by selective serotonin reuptake inhibitors, but not by direct stimulation of 5-HT1A receptor. Neuropharmacology. 2009;56(2):448\u201354.","journal-title":"Neuropharmacology."},{"key":"236_CR41","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bbr.2013.11.030","volume":"259","author":"JM Monti","year":"2014","unstructured":"Monti JM, Leopoldo M, Jantos H. Systemic administration and local microinjection into the central nervous system of the 5-HT(7) receptor agonist LP-211 modify the sleep-wake cycle in the rat. Behav Brain Res. 2014;259:321\u20139.","journal-title":"Behav Brain Res."},{"issue":"14","key":"236_CR42","doi-asserted-by":"crossref","first-page":"5351","DOI":"10.1523\/JNEUROSCI.21-14-05351.2001","volume":"21","author":"JC Ehlen","year":"2001","unstructured":"Ehlen JC, Grossman GH, Glass JD. In vivo resetting of the hamster circadian clock by 5-HT7 receptors in the suprachiasmatic nucleus. J Neurosci. 2001;21(14):5351\u20137.","journal-title":"J Neurosci."},{"issue":"1","key":"236_CR43","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuroscience.2007.10.028","volume":"152","author":"M Gardani","year":"2008","unstructured":"Gardani M, Biello SM. The effects of photic and nonphotic stimuli in the 5-HT7 receptor knockout mouse. Neuroscience. 2008;152(1):245\u201353.","journal-title":"Neuroscience."},{"issue":"1","key":"236_CR44","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neuropharm.2003.08.007","volume":"46","author":"J Sprouse","year":"2004","unstructured":"Sprouse J, Reynolds L, Li X, Braselton J, Schmidt A. 8-OH-DPAT as a 5-HT7 agonist: phase shifts of the circadian biological clock through increases in cAMP production. Neuropharmacology. 2004;46(1):52\u201362.","journal-title":"Neuropharmacology."},{"key":"236_CR45","first-page":"453","volume":"8","author":"J Shelton","year":"2014","unstructured":"Shelton J, Yun S, Losee OS, Turek F, Bonaventure P, Dvorak C, Lovenberg T, Dugovic C. Selective pharmacological blockade of the 5-HT7 receptor attenuates light and 8-OH-DPAT induced phase shifts of mouse circadian wheel running activity. Front Behav Neurosci. 2014;8:453.","journal-title":"Front Behav Neurosci."},{"issue":"2","key":"236_CR46","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.neuropharm.2011.09.012","volume":"62","author":"W Adriani","year":"2012","unstructured":"Adriani W, Travaglini D, Lacivita E, Saso L, Leopoldo M, Laviola G. Modulatory effects of two novel agonists for serotonin receptor 7 on emotion, motivation and circadian rhythm profiles in mice. Neuropharmacology. 2012;62(2):833\u201342.","journal-title":"Neuropharmacology."},{"key":"236_CR47","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.physbeh.2012.12.009","volume":"110\u2013111","author":"L Westrich","year":"2013","unstructured":"Westrich L, Sprouse J, Sanchez C. The effects of combining serotonin reuptake inhibition and 5-HT7 receptor blockade on circadian rhythm regulation in rodents. Physiol Behav. 2013;110\u2013111:42\u201350.","journal-title":"Physiol Behav."},{"issue":"2","key":"236_CR48","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0006-8993(97)00102-9","volume":"755","author":"SW Ying","year":"1997","unstructured":"Ying SW, Rusak B. 5-HT7 receptors mediate serotonergic effects on light-sensitive suprachiasmatic nucleus neurons. Brain Res. 1997;755(2):246\u201354.","journal-title":"Brain Res."},{"issue":"1","key":"236_CR49","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1471-4159.2009.06128.x","volume":"110","author":"M Cuesta","year":"2009","unstructured":"Cuesta M, Clesse D, Pevet P, Challet E. New light on the serotonergic paradox in the rat circadian system. J Neurochem. 2009;110(1):231\u201343.","journal-title":"J Neurochem."},{"issue":"6","key":"236_CR50","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.neuropharm.2012.06.061","volume":"63","author":"TM Eriksson","year":"2012","unstructured":"Eriksson TM, Holst S, Stan TL, Hager T, Sjogren B, Ogren SO, Svenningsson P, Stiedl O. 5-HT1A and 5-HT7 receptor crosstalk in the regulation of emotional memory: implications for effects of selective serotonin reuptake inhibitors. Neuropharmacology. 2012;63(6):1150\u201360.","journal-title":"Neuropharmacology."},{"key":"236_CR51","first-page":"382","volume":"89C","author":"L Westrich","year":"2014","unstructured":"Westrich L, Haddjeri N, Dkhissi-Benyahya O, Sanchez C. Involvement of 5-HT receptors in vortioxetine\u2019s modulation of circadian rhythms and episodic memory in rodents. Neuropharmacology. 2014;89C:382\u201390.","journal-title":"Neuropharmacology."},{"issue":"7","key":"236_CR52","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1111\/j.1460-9568.2004.03288.x","volume":"19","author":"AJ Roberts","year":"2004","unstructured":"Roberts AJ, Krucker T, Levy CL, Slanina KA, Sutcliffe JG, Hedlund PB. Mice lacking 5-HT receptors show specific impairments in contextual learning. Eur J Neurosci. 2004;19(7):1913\u201322.","journal-title":"Eur J Neurosci."},{"issue":"3","key":"236_CR53","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.neulet.2006.12.054","volume":"414","author":"PB Hedlund","year":"2007","unstructured":"Hedlund PB, Sutcliffe JG. The 5-HT7 receptor influences stereotypic behavior in a model of obsessive-compulsive disorder. Neurosci Lett. 2007;414(3):247\u201351.","journal-title":"Neurosci Lett."},{"issue":"1","key":"236_CR54","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00213-014-3639-6","volume":"232","author":"R Canese","year":"2015","unstructured":"Canese R, Zoratto F, Altabella L, Porcari P, Mercurio L, de Pasquale F, Butti E, Martino G, Lacivita E, Leopoldo M, Laviola G, Adriani W. Persistent modification of forebrain networks and metabolism in rats following adolescent exposure to a 5-HT7 receptor agonist. Psychopharmacology (Berl). 2015;232(1):75\u201389.","journal-title":"Psychopharmacology (Berl)."},{"issue":"4","key":"236_CR55","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hipo.20938","volume":"22","author":"AJ Roberts","year":"2012","unstructured":"Roberts AJ, Hedlund PB. The 5-HT(7) receptor in learning and memory. Hippocampus. 2012;22(4):762\u201371.","journal-title":"Hippocampus."},{"issue":"1","key":"236_CR56","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bbr.2009.03.011","volume":"202","author":"G Sarkisyan","year":"2009","unstructured":"Sarkisyan G, Hedlund PB. The 5-HT7 receptor is involved in allocentric spatial memory information processing. Behav Brain Res. 2009;202(1):26\u201331.","journal-title":"Behav Brain Res."},{"key":"236_CR57","first-page":"448","volume":"8","author":"G Beaudet","year":"2014","unstructured":"Beaudet G, Bouet V, Jozet-Alves C, Schumann-Bard P, Dauphin F, Paizanis E, Boulouard M, Freret T. Spatial memory deficit across aging: current insights of the role of 5-HT7 receptors. Front Behav Neurosci. 2014;8:448.","journal-title":"Front Behav Neurosci."},{"issue":"1","key":"236_CR58","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bbr.2011.12.009","volume":"228","author":"KA Waters","year":"2012","unstructured":"Waters KA, Stean TO, Hammond B, Virley DJ, Upton N, Kew JN, Hussain I. Effects of the selective 5-HT(7) receptor antagonist SB-269970 in animal models of psychosis and cognition. Behav Brain Res. 2012;228(1):211\u20138.","journal-title":"Behav Brain Res."},{"issue":"2","key":"236_CR59","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00213-013-3247-x","volume":"231","author":"T Freret","year":"2014","unstructured":"Freret T, Paizanis E, Beaudet G, Gusmao-Montaigne A, Nee G, Dauphin F, Bouet V, Boulouard M. Modulation of 5-HT7 receptor: effect on object recognition performances in mice. Psychopharmacology (Berl). 2014;231(2):393\u2013400.","journal-title":"Psychopharmacology (Berl)."},{"issue":"1","key":"236_CR60","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.neuroscience.2007.07.043","volume":"149","author":"SJ Ballaz","year":"2007","unstructured":"Ballaz SJ, Akil H, Watson SJ. The 5-HT7 receptor: role in novel object discrimination and relation to novelty-seeking behavior. Neuroscience. 2007;149(1):192\u2013202.","journal-title":"Neuroscience."},{"issue":"2","key":"236_CR61","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.neuroscience.2007.04.024","volume":"147","author":"SJ Ballaz","year":"2007","unstructured":"Ballaz SJ, Akil H, Watson SJ. Analysis of 5-HT6 and 5-HT7 receptor gene expression in rats showing differences in novelty-seeking behavior. Neuroscience. 2007;147(2):428\u201338.","journal-title":"Neuroscience."},{"issue":"1","key":"236_CR62","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.bbr.2007.11.023","volume":"195","author":"A Meneses","year":"2008","unstructured":"Meneses A, Perez-Garcia G, Liy-Salmeron G, Flores-Galvez D, Castillo C, Castillo E. The effects of the 5-HT(6) receptor agonist EMD and the 5-HT(7) receptor agonist AS19 on memory formation. Behav Brain Res. 2008;195(1):112\u20139.","journal-title":"Behav Brain Res."},{"issue":"1","key":"236_CR63","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bbr.2005.04.014","volume":"163","author":"GS Perez-Garcia","year":"2005","unstructured":"Perez-Garcia GS, Meneses A. Effects of the potential 5-HT7 receptor agonist AS 19 in an autoshaping learning task. Behav Brain Res. 2005;163(1):136\u201340.","journal-title":"Behav Brain Res."},{"issue":"3","key":"236_CR64","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00213-014-3693-0","volume":"232","author":"A Meneses","year":"2015","unstructured":"Meneses A, Perez-Garcia G, Liy-Salmeron G, Ponce-Lopez T, Lacivita E, Leopoldo M. 5-HT receptor activation: procognitive and antiamnesic effects. Psychopharmacology (Berl). 2015;232(3):595\u2013603.","journal-title":"Psychopharmacology (Berl)."},{"key":"236_CR65","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3389\/fnbeh.2014.00207","volume":"8","author":"A Meneses","year":"2014","unstructured":"Meneses A. 5-HT7 receptor stimulation and blockade: a therapeutic paradox about memory formation and amnesia. Front Behav Neurosci. 2014;8:207.","journal-title":"Front Behav Neurosci."},{"key":"236_CR66","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bbr.2013.04.008","volume":"248","author":"A Nikiforuk","year":"2013","unstructured":"Nikiforuk A, Popik P. Amisulpride promotes cognitive flexibility in rats: the role of 5-HT7 receptors. Behav Brain Res. 2013;248:136\u201340.","journal-title":"Behav Brain Res."},{"issue":"1","key":"236_CR67","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bbr.2007.12.020","volume":"195","author":"A Gasbarri","year":"2008","unstructured":"Gasbarri A, Cifariello A, Pompili A, Meneses A. Effect of 5-HT(7) antagonist SB-269970 in the modulation of working and reference memory in the rat. Behav Brain Res. 2008;195(1):164\u201370.","journal-title":"Behav Brain Res."},{"issue":"3","key":"236_CR68","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1515\/revneuro-2013-0066","volume":"25","author":"A Gasbarri","year":"2014","unstructured":"Gasbarri A, Pompili A. Serotonergic 5-HT7 receptors and cognition. Rev Neurosci. 2014;25(3):311\u201323.","journal-title":"Rev Neurosci."},{"issue":"3","key":"236_CR69","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s12035-011-8175-3","volume":"43","author":"A Matthys","year":"2011","unstructured":"Matthys A, Haegeman G, Van CK, Vanhoenacker P. Role of the 5-HT7 receptor in the central nervous system: from current status to future perspectives. Mol Neurobiol. 2011;43(3):228\u201353.","journal-title":"Mol Neurobiol."},{"issue":"1\u20133","key":"236_CR70","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.schres.2006.07.003","volume":"88","author":"B Dean","year":"2006","unstructured":"Dean B, Pavey G, Thomas D, Scarr E. Cortical serotonin7, 1D and 1F receptors: effects of schizophrenia, suicide and antipsychotic drug treatment. Schizophr Res. 2006;88(1\u20133):265\u201374.","journal-title":"Schizophr Res."},{"issue":"1","key":"236_CR71","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0920-9964(01)00323-1","volume":"57","author":"SZ East","year":"2002","unstructured":"East SZ, Burnet PW, Kerwin RW, Harrison PJ. An RT-PCR study of 5-HT(6) and 5-HT(7) receptor mRNAs in the hippocampal formation and prefrontal cortex in schizophrenia. Schizophr Res. 2002;57(1):15\u201326.","journal-title":"Schizophr Res."},{"issue":"4","key":"236_CR72","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/sj.npp.1300901","volume":"31","author":"M Ikeda","year":"2006","unstructured":"Ikeda M, Iwata N, Kitajima T, Suzuki T, Yamanouchi Y, Kinoshita Y, Ozaki N. Positive association of the serotonin 5-HT7 receptor gene with schizophrenia in a Japanese population. Neuropsychopharmacology. 2006;31(4):866\u201371.","journal-title":"Neuropsychopharmacology."},{"key":"236_CR73","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.pharmthera.2010.07.004","volume":"128","author":"JC Neill","year":"2010","unstructured":"Neill JC, Barnes S, Cook S, Grayson B, Idris NF, McLean SL, Snigdha S, Rajagopal L, Harte MK. Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism. Pharmacol Ther. 2010;128:419\u201332.","journal-title":"Pharmacol Ther."},{"issue":"2","key":"236_CR74","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/FBP.0b013e3282f62d8c","volume":"19","author":"R Galici","year":"2008","unstructured":"Galici R, Boggs JD, Miller KL, Bonaventure P, Atack JR. Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity. Behav Pharmacol. 2008;19(2):153\u20139.","journal-title":"Behav Pharmacol."},{"issue":"4","key":"236_CR75","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0091-3057(01)00744-4","volume":"71","author":"B Pouzet","year":"2002","unstructured":"Pouzet B, Didriksen M, Arnt J. Effects of the 5-HT(7) receptor antagonist SB-258741 in animal models for schizophrenia. Pharmacol Biochem Behav. 2002;71(4):655\u201365.","journal-title":"Pharmacol Biochem Behav."},{"issue":"2","key":"236_CR76","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/schbul\/19.2.233","volume":"19","author":"DL Braff","year":"1993","unstructured":"Braff DL. Information processing and attention dysfunctions in schizophrenia. Schizophr Bull. 1993;19(2):233\u201359.","journal-title":"Schizophr Bull."},{"issue":"6","key":"236_CR77","doi-asserted-by":"crossref","first-page":"e66695","DOI":"10.1371\/journal.pone.0066695","volume":"8","author":"A Nikiforuk","year":"2013","unstructured":"Nikiforuk A, Kos T, Fijal K, Holuj M, Rafa D, Popik P. Effects of the selective 5-HT7 receptor antagonist SB-269970 and amisulpride on ketamine-induced schizophrenia-like deficits in rats. PLoS One. 2013;8(6):e66695.","journal-title":"PLoS One."},{"issue":"1","key":"236_CR78","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.biopsych.2006.12.011","volume":"63","author":"S Semenova","year":"2008","unstructured":"Semenova S, Geyer MA, Sutcliffe JG, Markou A, Hedlund PB. Inactivation of the 5-HT(7) receptor partially blocks phencyclidine-induced disruption of prepulse inhibition. Biol Psychiatry. 2008;63(1):98\u2013105.","journal-title":"Biol Psychiatry."},{"issue":"3","key":"236_CR79","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00213-009-1618-0","volume":"206","author":"SL McLean","year":"2009","unstructured":"McLean SL, Woolley ML, Thomas D, Neill JC. Role of 5-HT receptor mechanisms in sub-chronic PCP-induced reversal learning deficits in the rat. Psychopharmacology (Berl). 2009;206(3):403\u201314.","journal-title":"Psychopharmacology (Berl)."},{"issue":"6","key":"236_CR80","doi-asserted-by":"crossref","first-page":"e20210","DOI":"10.1371\/journal.pone.0020210","volume":"6","author":"P Bonaventure","year":"2011","unstructured":"Bonaventure P, Aluisio L, Shoblock J, Boggs JD, Fraser IC, Lord B, Lovenberg TW, Galici R. Pharmacological blockade of serotonin 5-HT(7) receptor reverses working memory deficits in rats by normalizing cortical glutamate neurotransmission. PLoS One. 2011;6(6):e20210.","journal-title":"PLoS One."},{"issue":"2","key":"236_CR81","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bbr.2004.04.026","volume":"155","author":"A Meneses","year":"2004","unstructured":"Meneses A. Effects of the 5-HT7 receptor antagonists SB-269970 and DR 4004 in autoshaping Pavlovian\/instrumental learning task. Behav Brain Res. 2004;155(2):275\u201382.","journal-title":"Behav Brain Res."},{"issue":"9","key":"236_CR82","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/hipo.20459","volume":"18","author":"G Liy-Salmeron","year":"2008","unstructured":"Liy-Salmeron G, Meneses A. Effects of 5-HT drugs in prefrontal cortex during memory formation and the ketamine amnesia-model. Hippocampus. 2008;18(9):965\u201374.","journal-title":"Hippocampus."},{"issue":"2","key":"236_CR83","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1124\/jpet.111.180638","volume":"338","author":"M Horiguchi","year":"2011","unstructured":"Horiguchi M, Huang M, Meltzer HY. The role of 5-hydroxytryptamine 7 receptors in the phencyclidine-induced novel object recognition deficit in rats. J Pharmacol Exp Ther. 2011;338(2):605\u201314.","journal-title":"J Pharmacol Exp Ther."},{"issue":"1","key":"236_CR84","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.bbr.2011.01.034","volume":"220","author":"T Horisawa","year":"2011","unstructured":"Horisawa T, Ishibashi T, Nishikawa H, Enomoto T, Toma S, Ishiyama T, Taiji M. The effects of selective antagonists of serotonin 5-HT7 and 5-HT1A receptors on MK-801-induced impairment of learning and memory in the passive avoidance and Morris water maze tests in rats: mechanistic implications for the beneficial effects of the novel atypical antipsychotic lurasidone. Behav Brain Res. 2011;220(1):83\u201390.","journal-title":"Behav Brain Res."},{"key":"236_CR85","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bbr.2013.01.026","volume":"244","author":"T Horisawa","year":"2013","unstructured":"Horisawa T, Nishikawa H, Toma S, Ikeda A, Horiguchi M, Ono M, Ishiyama T, Taiji M. The role of 5-HT7 receptor antagonism in the amelioration of MK-801-induced learning and memory deficits by the novel atypical antipsychotic drug lurasidone. Behav Brain Res. 2013;244:66\u20139.","journal-title":"Behav Brain Res."},{"key":"236_CR86","author":"M Ho\u0142uj","year":"2015","unstructured":"Ho\u0142uj M, Popik P, Nikiforuk A. Improvement of ketamine-induced social withdrawal in rats: the role of 5-HT7 receptors. Behav Pharmacol. 2015. doi: 10.1097\/FBP.0000000000000132 .","journal-title":"Behav Pharmacol."},{"issue":"3","key":"236_CR87","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0022-3565(25)38596-4","volume":"268","author":"BL Roth","year":"1994","unstructured":"Roth BL, Craigo SC, Choudhary MS, Uluer A, Monsma FJ Jr, Shen Y, Meltzer HY, Sibley DR. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J Pharmacol Exp Ther. 1994;268(3):1403\u201310.","journal-title":"J Pharmacol Exp Ther."},{"issue":"3","key":"236_CR88","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.pain.2010.03.007","volume":"149","author":"A Brenchat","year":"2010","unstructured":"Brenchat A, Nadal X, Romero L, Ovalle S, Muro A, Sanchez-Arroyos R, Portillo-Salido E, Pujol M, Montero A, Codony X, Burgueno J, Zamanillo D, Hamon M, Maldonado R, Vela JM. Pharmacological activation of 5-HT7 receptors reduces nerve injury-induced mechanical and thermal hypersensitivity. Pain. 2010;149(3):483\u201394.","journal-title":"Pain."},{"issue":"6","key":"236_CR89","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.neuropharm.2012.07.023","volume":"63","author":"F Viguier","year":"2012","unstructured":"Viguier F, Michot B, Kayser V, Bernard JF, Vela JM, Hamon M, Bourgoin S. GABA, but not opioids, mediates the anti-hyperalgesic effects of 5-HT7 receptor activation in rats suffering from neuropathic pain. Neuropharmacology. 2012;63(6):1093\u2013106.","journal-title":"Neuropharmacology."},{"issue":"2","key":"236_CR90","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.pbb.2012.05.006","volume":"102","author":"A Ulugol","year":"2012","unstructured":"Ulugol A, Oltulu C, Gunduz O, Citak C, Carrara R, Shaqaqi MR, Sanchez AM, Dogrul A. 5-HT7 receptor activation attenuates thermal hyperalgesia in streptozocin-induced diabetic mice. Pharmacol Biochem Behav. 2012;102(2):344\u20138.","journal-title":"Pharmacol Biochem Behav."},{"issue":"1\u20133","key":"236_CR91","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejphar.2013.01.074","volume":"716","author":"F Viguier","year":"2013","unstructured":"Viguier F, Michot B, Hamon M, Bourgoin S. Multiple roles of serotonin in pain control mechanisms\u2013implications of 5-HT(7) and other 5-HT receptor types. Eur J Pharmacol. 2013;716(1\u20133):8\u201316.","journal-title":"Eur J Pharmacol."},{"issue":"1","key":"236_CR92","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejpain.2011.07.004","volume":"16","author":"A Brenchat","year":"2012","unstructured":"Brenchat A, Zamanillo D, Hamon M, Romero L, Vela JM. Role of peripheral versus spinal 5-HT(7) receptors in the modulation of pain undersensitizing conditions. Eur J Pain. 2012;16(1):72\u201381.","journal-title":"Eur J Pain."},{"issue":"1\u20132","key":"236_CR93","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.neulet.2004.01.072","volume":"359","author":"M Graf","year":"2004","unstructured":"Graf M, Jakus R, Kantor S, Levay G, Bagdy G. Selective 5-HT1A and 5-HT7 antagonists decrease epileptic activity in the WAG\/Rij rat model of absence epilepsy. Neurosci Lett. 2004;359(1\u20132):45\u20138.","journal-title":"Neurosci Lett."},{"issue":"1\u20133","key":"236_CR94","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejphar.2012.04.011","volume":"685","author":"Z Yang","year":"2012","unstructured":"Yang Z, Liu X, Yin Y, Sun S, Deng X. Involvement of 5-HT(7) receptors in the pathogenesis of temporal lobe epilepsy. Eur J Pharmacol. 2012;685(1\u20133):52\u20138.","journal-title":"Eur J Pharmacol."},{"issue":"1","key":"236_CR95","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.eplepsyres.2007.03.017","volume":"75","author":"JM Witkin","year":"2007","unstructured":"Witkin JM, Baez M, Yu J, Barton ME, Shannon HE. Constitutive deletion of the serotonin-7 (5-HT(7)) receptor decreases electrical and chemical seizure thresholds. Epilepsy Res. 2007;75(1):39\u201345.","journal-title":"Epilepsy Res."},{"key":"236_CR96","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.brainres.2007.01.019","volume":"1141","author":"D Pericic","year":"2007","unstructured":"Pericic D, Svob SD. The role of 5-HT(7) receptors in the control of seizures. Brain Res. 2007;1141:48\u201355.","journal-title":"Brain Res."},{"key":"236_CR97","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3389\/fncel.2014.00250","volume":"8","author":"L Ciranna","year":"2014","unstructured":"Ciranna L, Catania MV. 5-HT7 receptors as modulators of neuronal excitability, synaptic transmission and plasticity: physiological role and possible implications in autism spectrum disorders. Front Cell Neurosci. 2014;8:250.","journal-title":"Front Cell Neurosci."},{"issue":"11","key":"236_CR98","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.biopsych.2012.06.008","volume":"72","author":"L Costa","year":"2012","unstructured":"Costa L, Spatuzza M, D\u2019Antoni S, Bonaccorso CM, Trovato C, Musumeci SA, Leopoldo M, Lacivita E, Catania MV, Ciranna L. Activation of 5-HT7 serotonin receptors reverses metabotropic glutamate receptor-mediated synaptic plasticity in wild-type and Fmr1 knockout mice, a model of Fragile X syndrome. Biol Psychiatry. 2012;72(11):924\u201333.","journal-title":"Biol Psychiatry."},{"issue":"11","key":"236_CR99","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1038\/npp.2014.105","volume":"39","author":"B Filippis De","year":"2014","unstructured":"De Filippis B, Nativio P, Fabbri A, Ricceri L, Adriani W, Lacivita E, Leopoldo M, Passarelli F, Fuso A, Laviola G. Pharmacological stimulation of the brain serotonin receptor 7 as a novel therapeutic approach for Rett syndrome. Neuropsychopharmacology. 2014;39(11):2506\u201318.","journal-title":"Neuropsychopharmacology."},{"issue":"1","key":"236_CR100","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejphar.2007.01.019","volume":"560","author":"JA Terron","year":"2007","unstructured":"Terron JA, Martinez-Garcia E. 5-HT7 receptor-mediated dilatation in the middle meningeal artery of anesthetized rats. Eur J Pharmacol. 2007;560(1):56\u201360.","journal-title":"Eur J Pharmacol."},{"issue":"2","key":"236_CR101","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12031-014-0268-9","volume":"54","author":"X Wang","year":"2014","unstructured":"Wang X, Fang Y, Liang J, Yan M, Hu R, Pan X. 5-HT7 receptors are involved in neurogenic dural vasodilatation in an experimental model of migraine. J Mol Neurosci. 2014;54(2):164\u201370.","journal-title":"J Mol Neurosci."},{"issue":"3","key":"236_CR102","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1601-183X.2009.00486.x","volume":"8","author":"D Leo","year":"2009","unstructured":"Leo D, Adriani W, Cavaliere C, Cirillo G, Marco EM, Romano E, di Porzio U, Papa M, Perrone-Capano C, Laviola G. Methylphenidate to adolescent rats drives enduring changes of accumbal Htr7 expression: implications for impulsive behavior and neuronal morphology. Genes Brain Behav. 2009;8(3):356\u201368.","journal-title":"Genes Brain Behav."},{"issue":"4","key":"236_CR103","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/syn.21724","volume":"68","author":"LA Ruocco","year":"2014","unstructured":"Ruocco LA, Romano E, Treno C, Lacivita E, Arra C, Gironi-Carnevale UA, Travaglini D, Leopoldo M, Laviola G, Sadile AG, Adriani W. Emotional and risk seeking behavior after prepuberal subchronic or adult acute stimulation of 5-HT7-Rs in Naples High Excitability rats. Synapse. 2014;68(4):159\u201367.","journal-title":"Synapse."},{"key":"236_CR104","first-page":"448","volume":"8","author":"SR Hauser","year":"2014","unstructured":"Hauser SR, Hedlund PB, Roberts AJ, Sari Y, Bell RL, Engleman EA. The 5-HT7 receptor as a potential target for treating drug and alcohol abuse. Front Neurosci. 2014;8:448.","journal-title":"Front Neurosci."},{"issue":"2","key":"236_CR105","doi-asserted-by":"crossref","first-page":"e00013","DOI":"10.1002\/prp2.13","volume":"1","author":"P Atanes","year":"2013","unstructured":"Atanes P, Lacivita E, Rodriguez J, Brea J, Burgueno J, Vela JM, Cadavid MI, Loza MI, Leopoldo M, Castro M. The arylpiperazine derivatives N-(4-cyanophenylmethyl)-4-(2-diphenyl)-1-piperazinehexanamide and N-benzyl-4-(2-diphenyl)-1-piperazinehexanamide exert a long-lasting inhibition of human serotonin 5-HT7 receptor binding and cAMP signaling. Pharmacol Res Perspect. 2013;1(2):e00013.","journal-title":"Pharmacol Res Perspect."},{"issue":"4","key":"236_CR106","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00221-013-3694-y","volume":"230","author":"E Gellynck","year":"2013","unstructured":"Gellynck E, Heyninck K, Andressen KW, Haegeman G, Levy FO, Vanhoenacker P, Van CK. The serotonin 5-HT7 receptors: two decades of research. Exp Brain Res. 2013;230(4):555\u201368.","journal-title":"Exp Brain Res."},{"key":"236_CR107","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3389\/fnbeh.2014.00306","volume":"8","author":"D Guseva","year":"2014","unstructured":"Guseva D, Wirth A, Ponimaskin E. Cellular mechanisms of the 5-HT7 receptor-mediated signaling. Front Behav Neurosci. 2014;8:306.","journal-title":"Front Behav Neurosci."},{"issue":"2","key":"236_CR108","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1124\/jpet.110.173948","volume":"336","author":"T Kenakin","year":"2011","unstructured":"Kenakin T. Functional selectivity and biased receptor signaling. J Pharmacol Exp Ther. 2011;336(2):296\u2013302.","journal-title":"J Pharmacol Exp Ther."},{"issue":"1\u20132","key":"236_CR109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2005.11.039","volume":"532","author":"KA Krobert","year":"2006","unstructured":"Krobert KA, Andressen KW, Levy FO. Heterologous desensitization is evoked by both agonist and antagonist stimulation of the human 5-HT(7) serotonin receptor. Eur J Pharmacol. 2006;532(1\u20132):1\u201310.","journal-title":"Eur J Pharmacol."},{"issue":"3","key":"236_CR110","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1021\/jm991151j","volume":"43","author":"PJ Lovell","year":"2000","unstructured":"Lovell PJ, Bromidge SM, Dabbs S, Duckworth DM, Forbes IT, Jennings AJ, King FD, Middlemiss DN, Rahman SK, Saunders DV, Collin LL, Hagan JJ, Riley GJ, Thomas DR. A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970). J Med Chem. 2000;43(3):342\u20135.","journal-title":"J Med Chem."},{"issue":"4","key":"236_CR111","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1254\/jphs.11039SC","volume":"116","author":"A Brenchat","year":"2011","unstructured":"Brenchat A, Ejarque M, Zamanillo D, Vela JM, Romero L. Potentiation of morphine analgesia by adjuvant activation of 5-HT7 receptors. J Pharmacol Sci. 2011;116(4):388\u201391.","journal-title":"J Pharmacol Sci."}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-015-0236-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-015-0236-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-015-0236-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T02:14:55Z","timestamp":1747707295000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-015-0236-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,27]]},"references-count":111,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["236"],"URL":"https:\/\/doi.org\/10.1007\/s40263-015-0236-0","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,27]]}}}